STOCK TITAN

Cross Country Healthcare (CCRN) CFO reports merger cash-out at $13.25

(Very High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cross Country Healthcare Inc. Chief Financial Officer William J. Burns reported equity changes in connection with a merger in which the company became a wholly owned subsidiary of KL Criss Cross Intermediate, LLC. At the merger’s Effective Time, 336,438 common shares and 104,157 shares underlying performance-based restricted stock awards were disposed to the issuer, each automatically converted into the right to receive $13.25 in cash per share. The 104,157 performance-based awards first vested at target levels and were recorded as an acquisition at no cost before being cancelled for the same cash consideration.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Burns William J.
Role Chief Financial Officer
Type Security Shares Price Value
Disposition Common Stock F1, F2 336,438 $13.25 $4.46M
Grant/Award Common Stock F3 104,157 $0.00 $0.00
Disposition Common Stock F1, F2, F3 104,157 $13.25 $1.38M
Holdings After Transaction: Common Stock — 0 shares (Direct)
Footnotes (3)
  1. F1. Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
  2. F2. at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.
  3. F3. At the Effective Time, each performance-based restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested (at target levels) and cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award (at target) immediately prior to the Effective Time multiplied by the Merger Consideration.
Common shares disposed to issuer 336,438 shares Disposition of common stock at $13.25 per share in connection with merger
Performance-based awards vested 104,157 shares Performance-based restricted stock awards vested at target and recorded as acquisition at $0.00
Performance-based shares disposed 104,157 shares Cancellation and disposition to issuer at $13.25 per share at the Effective Time
Merger cash consideration $13.25 per share Each share of issuer common stock converted into cash merger consideration
Agreement and Plan of Merger regulatory
"Pursuant to the Agreement and Plan of Merger (the "Merger Agreement")"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Merger Consideration financial
"converted into the right to receive $13.25 in cash (the "Merger Consideration")"
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
Effective Time regulatory
"At the effective time of the Merger (the "Effective Time"), each share..."
The exact clock time when a regulatory filing, approval, or corporate action formally becomes legally active; from that moment the change is binding and can be acted on. Investors care because the effective time marks when ownership, rights, trading rules, or new securities take effect — like a light switch turning on a contract or transaction — which determines when risks, benefits and market reactions begin.
performance-based restricted stock award financial
"each performance-based restricted stock award with respect to shares of Common Stock"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock transactions did Cross Country Healthcare (CCRN) CFO William J. Burns report?

William J. Burns reported dispositions of 336,438 common shares and 104,157 shares underlying performance-based restricted stock awards, all occurring at the merger’s Effective Time. Each affected share was converted into the right to receive $13.25 in cash from the acquiring parent entity.

How many Cross Country Healthcare (CCRN) shares held by the CFO were converted to cash in the merger?

Burns had 336,438 common shares and an additional 104,157 shares from performance-based restricted stock awards disposed to the issuer in connection with the merger. Every disposed share was automatically converted into the right to receive $13.25 in cash as merger consideration.

What cash consideration did Cross Country Healthcare (CCRN) shareholders receive in the merger?

Each share of Cross Country Healthcare common stock was converted into the right to receive $13.25 in cash. The same $13.25 per share merger consideration applied to shares underlying restricted stock and performance-based restricted stock awards that vested and were cancelled at the Effective Time.

What happened to Cross Country Healthcare (CCRN) restricted stock awards at the merger’s Effective Time?

Each restricted stock award became fully vested, then was cancelled and converted to cash at closing. Holders received an amount equal to the number of shares subject to the award multiplied by the $13.25 merger consideration, replacing their equity position with a cash entitlement.

How were Cross Country Healthcare (CCRN) performance-based restricted stock awards treated in the merger?

Performance-based restricted stock awards vested at target levels at the Effective Time, then were fully cancelled. Each award was converted into cash equal to the target number of underlying shares multiplied by the $13.25 merger consideration, eliminating those equity awards in exchange for cash value.

Who acquired Cross Country Healthcare Inc. (CCRN) in this merger transaction?

Cross Country Healthcare became a wholly owned subsidiary of KL Criss Cross Intermediate, LLC. This occurred when KL Criss Cross Merger Sub, Inc. merged with and into Cross Country Healthcare, with the issuer surviving the merger as a subsidiary of the private parent entity.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burns William J.

(Last)(First)(Middle)
C/O CROSS COUNTRY HEALTHCARE, INC.
5201 CONGRESS AVENUE, SUITE 160

(Street)
BOCA RATON FLORIDA 33487

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CROSS COUNTRY HEALTHCARE INC [ CCRN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/21/2026D(1)(2)336,438D$13.250D
Common Stock07/21/2026A(3)104,157A$0104,157D
Common Stock07/21/2026D(1)(2)(3)104,157D$13.250D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
2. at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.
3. At the Effective Time, each performance-based restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested (at target levels) and cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award (at target) immediately prior to the Effective Time multiplied by the Merger Consideration.
/s/ William J. Burns07/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)